C

CERo Therapeutics, Inc.

12 employees

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cellular Immunotherapy
Synthetic Biology
Tumor Immunology
Gene Engineering
Flow Cytometry
Solid Tumors
Molecular Immunology
Immuno Oncology
Therapeutics
Immunology
Molecular Biology
Adoptive Cell Therapy
Hematopoietic Cell Transplantation

Date founded

2018

Funding rounds raised

Total raised

$40M

from 3 investors over 3 rounds

C

CERo Therapeutics, Inc. raised $40M on March 18, 2020

Investors: Sequoia Capital China, ARCH Venture Partners and Lyell Immunopharma

FAQ